Hans-Jürgen Berger

Hans-Jürgen Berger has extensive experience in the pharmaceutical industry, with a focus on oncology and hematology. Hans-Jürgen is currently serving as the Marketing Director Oncology at Stemline Therapeutics since October 2022. Prior to this, they worked as the Marketing Director Hematology at Bristol Myers Squibb from July 2021 to October 2022.

Hans-Jürgen also has a long history with Celgene, where they held various marketing roles. Hans-Jürgen served as the Director Marketing Hematology from October 2019 to June 2021, Associate Director Marketing Oncology from October 2018 to September 2019, Marketing Manager Oncology from October 2014 to September 2018, Senior Product Manager Oncology from April 2013 to September 2014, Product Manager Oncology from October 2011 to March 2013, Associate Product Manager Oncology from March 2011 to September 2011, and as a Medical Communication Specialist from October 2008 to February 2011.

Before joining Celgene, Hans-Jürgen worked as a Key Account Manager Oncology at Bayer HealthCare from June 2006 to September 2008.

Hans-Jürgen Berger completed their education in the field of biology. From 1996 to 2001, they attended the University of Regensburg where they obtained a Diploma in Cell Biology. Later, from 2002 to 2006, they pursued a PhD in Molecular Biology at the Max-Planck-Institute of Biochemistry.